Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2005, p. 3530-3532, Vol. 43, No. 7
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.7.3530-3532.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Division of Infectious Diseases, Stanford University, Stanford, California,1 MRC Laboratories, Fajara, The Gambia,2 Bill and Melinda Gates Foundation, Seattle, Washington3
Received 11 March 2004/ Accepted 4 April 2005
Mycobacterium bovis is best identified by screening those isolates of the Mycobacterium tuberculosis complex that have any pyrazinamide (PZA) resistance, using a confirmatory test such as spoligotyping, biochemical testing, or genomic deletion analysis. The sensitivity for detection of M. bovis is lowered to 82% when only PZA-monoresistant isolates are screened.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»